Small molecule discoidin domain receptor kinase inhibitors and potential medical applications

Yupeng Li, Xiaoyun Lu, Xiaomei Ren, Ke Ding

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Discoidin domain receptors (DDRs) are members of the transmembrane receptor tyrosine kinase (RTK) superfamily which are distinguished from others by the presence of a discoidin motif in the extracellular domain and their utilization of collagens as internal ligands. Two types of DDRs, DDR1 and DDR2, have been identified with distinct expression profiles and ligand specificities. These DDRs play important roles in the regulation of fundamental cellular process, such as proliferation, survival, differentiation, adhesion, and matrix remodeling. They have also been closely linked to a number of human diseases, including various fibrotic disorders, atherosclerosis, and cancer. As a consequence, DDRs have been considered as novel potential molecular targets for drug discovery and increasing efforts are being devoted to the identification of new small molecule inhibitors targeting the receptors. In this review, we offer a contemporary overview on the discovery of DDRs inhibitors and their potential medical application for the treatment of cancer and inflammation related disorders.

Original languageEnglish (US)
Pages (from-to)3287-3301
Number of pages15
JournalJournal of medicinal chemistry
Volume58
Issue number8
DOIs
StatePublished - Apr 23 2015
Externally publishedYes

Fingerprint Dive into the research topics of 'Small molecule discoidin domain receptor kinase inhibitors and potential medical applications'. Together they form a unique fingerprint.

Cite this